Over the past 2 decades, self-injection therapy has proven to be both safe and efficacious, and is considered the best second-line drug therapy for the management of erectile dysfunction.

eTheRNA was founded in January 2013 out of the VUB Laboratory for Molecular and Cellular Therapy (LMCT). Headed by Prof. Kris Thielemans in tandem with Prof. Bart Neyns, the LMCT has driven both the ...